VMM17

规格:

货期:

编号:TS145048

品牌:Testobio

产品名称：	VMM17
商品货号：	TS145048
Organism：	Homo sapiens, human
Tissue：	Melanoma, Lymph Node Metastasis
Cell Type：	Melanocyte
Product Format：	frozen
Morphology：	Epithelial-like
Culture Properties：	adherent
Biosafety Level：	1 Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Disease：	Melanoma, Stage IIIB; malignant
Age：	64
Gender：	Female
Ethnicity：	Caucasian
Applications：	Drug screening Development of targeted therapy Development of combination therapy Tumor vaccine development
Storage Conditions：	liquid nitrogen vapor phase
Images：
Derivation：	Derived from tumors taken from tumor-involved lymph nodes from patients at the University of Virginia
Clinical Data：	Primary Site: unknown; Metastatic Site: Lymph Node, Right Groin
Antigen Expression：	Positives: MAGE-A1, MAGE-A3
HLA Typing：	A2,?A2 OR A32,B65/14(B*14),B45,Cw8,Cw16 (HLA: test not performed. 2nd A Allele possible but not necessary; may have lost A33/34 allele.)
Comments：	NRAS: wt CDKN2A Mutation: R80 BRAF Mutation: V600E
Complete Growth Medium：	The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
Subculturing：	Volumes are for a T-75 flask; Adjust accordingly Remove and discard the cell culture medium from the flask. Rinse the cell monolayer with Dulbecco’s PBS without calcium or magnesium and remove. Add 3 to 4 ml of the trypsin-EDTA solution, rotate flask to rinse cell monolayer, remove trypsin solution, and incubate at 37^oC. Once the cells appear to be detached, add 10 ml of complete growth medium with a pipette to the cell suspension to inactivate the trypsin. Gently wash any remaining cells from the growth surface of the xa0 flask. Check the xa0cells with the microscope to be sure that most (>95%) are single cells. If cell clusters are apparent, continue to disperse the cells with gentle pipetting. Subculture as necessary. Place the flask back into the incubator. Examine the culture the following day to ensure the cells have reattached and are actively growing. Repeat when cells reach confluence.
Cryopreservation：	Fetal bovine serum, 90%; DMSO, 10%
Culture Conditions：	Temperature: 37°C Atmosphere: air, 95%; carbon dioxide (CO₂ ), 5%
STR Profile：	Amelogenin: X xa0 D5S818: 12 D13S317: 11,12xa0 D7S820: 9,10xa0 D16S539: 12xa0 vWA: 14,17 xa0xa0 TH01: 9.3 xa0 TPOX: 8,11 CSF1PO: 10,12
Sterility Tests：	Pass
Name of Depositor：	Craig L. Slingluff, Jr. M.D.
Passage History：	Unknown. 2 passages from 12/27/1996 frozen cell line stock, but it is not known how long the line was in culture after being established from tumor tissue obtained in 1994.
Year of Origin：	1994
References：	Slingluff C, et al. Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens. Cancer Immunol. Immunother. 48:661-672, 2000. PubMed: 10752474 Molhoek K, et al. Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor-2. Cancer Res. 68: (11), 2008. PubMed: 18519701 Molhoek K, et al. Comprehensive analysis of RTK activation in human melanomas reveals autocrine signaling through IGF-1R. Melanoma Res 21(4): 274–284, 2011. PubMed: 21654344

首页 > 产品中心 > 微生物培养 > 菌株 > null > VMM17

产品中心 Product Center

联系我们CONTACT US

0574-87917803
24小时服务热线
testobio@163.com
销售邮箱
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址

联系方式

章丽敏
17757489010
朱静
18067106081
李晴
18067408036
李晶晶
13375187189
周雪
13372109301

VMM17

货号: TS145048
好评

有货

品牌 : TESTOBIO

加入购物车在线咨询

产品名称：	VMM17
商品货号：	TS145048
Organism：	Homo sapiens, human
Tissue：	Melanoma, Lymph Node Metastasis
Cell Type：	Melanocyte
Product Format：	frozen
Morphology：	Epithelial-like
Culture Properties：	adherent
Biosafety Level：	1 Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Disease：	Melanoma, Stage IIIB; malignant
Age：	64
Gender：	Female
Ethnicity：	Caucasian
Applications：	Drug screening Development of targeted therapy Development of combination therapy Tumor vaccine development
Storage Conditions：	liquid nitrogen vapor phase
Images：
Derivation：	Derived from tumors taken from tumor-involved lymph nodes from patients at the University of Virginia
Clinical Data：	Primary Site: unknown; Metastatic Site: Lymph Node, Right Groin
Antigen Expression：	Positives: MAGE-A1, MAGE-A3
HLA Typing：	A2,?A2 OR A32,B65/14(B*14),B45,Cw8,Cw16 (HLA: test not performed. 2nd A Allele possible but not necessary; may have lost A33/34 allele.)
Comments：	NRAS: wt CDKN2A Mutation: R80 BRAF Mutation: V600E
Complete Growth Medium：	The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
Subculturing：	Volumes are for a T-75 flask; Adjust accordingly Remove and discard the cell culture medium from the flask. Rinse the cell monolayer with Dulbecco’s PBS without calcium or magnesium and remove. Add 3 to 4 ml of the trypsin-EDTA solution, rotate flask to rinse cell monolayer, remove trypsin solution, and incubate at 37^oC. Once the cells appear to be detached, add 10 ml of complete growth medium with a pipette to the cell suspension to inactivate the trypsin. Gently wash any remaining cells from the growth surface of the xa0 flask. Check the xa0cells with the microscope to be sure that most (>95%) are single cells. If cell clusters are apparent, continue to disperse the cells with gentle pipetting. Subculture as necessary. Place the flask back into the incubator. Examine the culture the following day to ensure the cells have reattached and are actively growing. Repeat when cells reach confluence.
Cryopreservation：	Fetal bovine serum, 90%; DMSO, 10%
Culture Conditions：	Temperature: 37°C Atmosphere: air, 95%; carbon dioxide (CO₂ ), 5%
STR Profile：	Amelogenin: X xa0 D5S818: 12 D13S317: 11,12xa0 D7S820: 9,10xa0 D16S539: 12xa0 vWA: 14,17 xa0xa0 TH01: 9.3 xa0 TPOX: 8,11 CSF1PO: 10,12
Sterility Tests：	Pass
Name of Depositor：	Craig L. Slingluff, Jr. M.D.
Passage History：	Unknown. 2 passages from 12/27/1996 frozen cell line stock, but it is not known how long the line was in culture after being established from tumor tissue obtained in 1994.
Year of Origin：	1994
References：	Slingluff C, et al. Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens. Cancer Immunol. Immunother. 48:661-672, 2000. PubMed: 10752474 Molhoek K, et al. Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor-2. Cancer Res. 68: (11), 2008. PubMed: 18519701 Molhoek K, et al. Comprehensive analysis of RTK activation in human melanomas reveals autocrine signaling through IGF-1R. Melanoma Res 21(4): 274–284, 2011. PubMed: 21654344